Loading...
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
Objective To evaluate the effect of the oral synthetic δ-9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic, University Hospital of Aarhus, Denmark. Participan...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group Ltd.
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC498019/ https://ncbi.nlm.nih.gov/pubmed/15258006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38149.566979.AE |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|